Publication:
Primary Malignant Bone Tumours of Hematopoietic Origin: A Single-Centre, Retrospective Study

Simple item page
dc.authorscopusid56241636900
dc.authorscopusid58922910400
dc.authorscopusid58922910500
dc.authorscopusid58922477700
dc.authorscopusid57189903427
dc.authorscopusid6602451205
dc.contributor.authorBüyükceran, İ.
dc.contributor.authorAydin Şi̇Mşek, Ş.
dc.contributor.authorCengiz, T.
dc.contributor.authorMuslu, O.
dc.contributor.authorCoskun, H.S.
dc.contributor.authorDabak, N.
dc.date.accessioned2025-12-11T00:31:56Z
dc.date.issued2023
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Büyükceran] İsmail, Department of Orthopaedics and Traumatology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Aydin Şi̇Mşek] Şafak, Department of Orthopaedics and Traumatology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Cengiz] Tolgahan, Department of Orthopaedics and Traumatology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Muslu] Oğuzhan, Department of Orthopaedics and Traumatology, Hatay State Hospital, Hatay, Hatay, Turkey; [Coskun] Huseyin Sina, Department of Orthopaedics and Traumatology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Dabak] Nevzat, Department of Orthopaedics and Traumatology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractTumors of hematopoietic origin are rare tumors that can be confused with benign and malignant tumors of the bone with their clinical and morphological features. Plasma cell myeloma, solitary plasmacytoma, Non-Hodgkin Lymphoma, acute lymphoblastic leukemia/lymphoma, and Langerhans cell histiocytosis are hematological neoplasms that mainly involve the bone. Plasma cell myeloma is the most common primary malignant bone neoplasm, and diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma arising in bone. In this case report, we will retrospectively investigate the diagnosis and treatment management and postoperative clinical outcomes of patients diagnosed with tumors of hematopoietic origin, evaluated by the Bone and Soft Tissue Tumor Council between 2005 and 2021, and emphasize the importance of the approach to these tumors. © 2023 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.40.3.32
dc.identifier.endpage621en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85186942707
dc.identifier.scopusqualityQ4
dc.identifier.startpage619en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.40.3.32
dc.identifier.urihttps://hdl.handle.net/20.500.12712/37087
dc.identifier.volume40en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBone Neoplasmsen_US
dc.subjectHematopoietic Myelodysplasiaen_US
dc.subjectLeukemiaen_US
dc.subjectMultiple Myelomaen_US
dc.titlePrimary Malignant Bone Tumours of Hematopoietic Origin: A Single-Centre, Retrospective Studyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu